
    
      Is a clinical trial phase IV prospective, blind, controlled and random allocation of
      treatment with the active principle of amoxicillin 1000mg and 200mg Clavulanic acid,
      administered topically and dissolved in 500 ml of saline 0.9%. To demonstrate its
      effectiveness in the surgical wound infection prophylaxis be used in dirty/contaminated
      emergency surgery and be compared its effectiveness with the topical administration of normal
      saline only.
    
  